WS016

· Waterstone Pharmaceutical (Wuhan) Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WS016, covering 2024-02-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia [Phase 3]